Cytiva Cell and Gene Webinars and Podcasts

1. CRISPR Meets LNPs: A New Era In Cell And Gene Therapies 7/8/2025

   Explore how lipid nanoparticles are revolutionizing non-viral gene editing with scalable, efficient delivery for both ex vivo and in vivo applications, which features new CRISPR-LNP data in T cells.

2. Flexibility To Meet Your Process Needs 6/11/2025

   Explore a platform that adapts to your evolving workflow through real-world examples of how its flexibility supports diverse inputs, applications, and parameters to ensure consistency, scalability, and efficiency.

3. Prevent Batch Failures Before They Happen 6/11/2025

   Discover a platform that reduces operator errors and batch failures through automation, real-time monitoring, and intelligent design to ensure greater process reliability and consistent outcomes in your workflow.

4. Easy Integration Of A New Manufacturing Platform 6/11/2025

   Easily integrate an innovative platform into your manufacturing process with seamless onboarding, regulatory support, and expert guidance that is designed to help you confidently adopt good manufacturing practices.

5. Simplify CAR-T Cell Manufacturing With LNP-Mediated Delivery 6/3/2025

   Streamline CAR-T cell manufacturing with lipid nanoparticles delivering base editors to create fratricide-resistant, CD45-edited CAR45 T cells, which enables scalable, precise, and potent therapies for blood cancers.

6. Elevating AAV Manufacturing WithTailored Cell Lines 9/19/2024

   Skillfully crafted cell lines can substantially enhance vector purity and yield. Watch to explore a portfolio of engineered cell lines and their potential to transform the landscape of AAV production.

7. Insights And Strategies For GMP Manufacturing Of RNA-Lipid Nanoparticles 4/25/2024

   The emergence of RNA-encapsulated-lipid nanoparticles has introduced a seismic shift in biopharma innovation. But how will the industry adapt to diversifying applications and scales going forward?

8. Process Development Optimization For GMP CAR-T Manufacturing 4/17/2024

   Explore the significance of process development optimization and key considerations including selecting an outsourcing partner for PD projects, timing, technology, and process transfer, among others.

9. Bridging The Distance To Large-Scale GMP Manufacturing Of Viral Vectors 10/26/2023

   AGC Biologics discusses its journey to the successful implementation of iCELLis™ bioreactors in their AAV and lentivirus platforms.

10. Analyzing Full And Empty AAV Capsid Ratio – In Less Than 5 Minutes 10/24/2023

    Presenters show how Capto Q run on an ÄKTA pure 25 chromatography system can be used to determine the percentage of full capsids of AAV8 and AAV9 with low sample consumption.